Published in Health Risk Factor Week, March 22nd, 2005
According to scientists in Italy, "Aspirin may reduce the risk of colorectal neoplasia at doses similar to those recommended for the prevention of cardiovascular disease. Thus, we aimed to address whether enhanced platelet activation, as assessed by the measurement of the urinary, excretion of 11-dehydro-TXB2 (a major enzymatic metabolite of TXB2), occurs in patients with colorectal cancer."
M.G. Sciulli and colleagues of G. d'Annunzio University in Chieti explained, "In 10 patients with colorectal cancer, the urinary excretion of 11-dehydro-TXB2 was significantly...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week